INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD), which is characterized by hepatic steatosis, is considered the hepatic component of metabolic syndrome. NAFLD the most common chronic liver disease in Western nations and commonly occurs with co-morbidities such as obesity and Type 2 Diabetes (1, 2). In support of a causative role for NAFLD, subjects with NAFLD have an increased risk of developing Type homogenized using a needle and syringe instead of a nitrogen bomb and then centrifuged for 10 min at 1000xg. Following addition of 4 mL of buffer A the postnuclear supernatant was divided into two ultracentrifuge tubes, overlaid with 3 mL buffer B (20 mM HEPES pH 7.4, 100 mM KCl, 2 mM MgCl 2 and protease inhibitor cocktail) and centrifuged at 300,000xg for 1 hour at 4°C. The LD containing band was transferred to a fresh tube and centrifuged at 20,000xg for 20 min at 4°C. The underlying liquid was carefully removed and the LD fraction was washed six times with 200 µL buffer B to remove copurifying membranes (16, 17) and acetone precipitated overnight.
Protein Extraction
The LD precipitate was reconstituted with 65 µ l of protein solubilization buffer (7 M 
In-Solution Proteolytic Digestion and iTRAQ® Labeling
A 28 µg aliquot of each sample was transferred to a new 1.5 mL microfuge tube and brought to the same volume with protein solubilization buffer plus 8 mM methyl methanethiosulfonate. All samples were diluted four fold with 80% ultra-pure water, 20% methanol and trypsin (Promega) was added in a 1:35 ratio of trypsin to total protein. Samples were incubated overnight for 16 hours at 37°C after which they were frozen at -80°C for 0.5 hours and dried in a vacuum centrifuge. Subsequently, samples were cleaned with a 4 mL Extract Clean™ C18 SPE cartridge (Grace-Davidson) and eluates were vacuum dried and resuspended in 0.5 M triethylammonium bicarbonate, pH 8.5 to a final 1 µg/µl concentration.
Twenty-six µg aliquots for each sample were labeled with iTRAQ® 8-plex reagent (AB Sciex). After labeling, the samples were multiplexed together and dried in vacuo. The multiplexed sample was cleaned with a 4 mL Extract Clean™ C18 SPE cartridge, and the eluate was dried in vacuo.
Peptide Liquid Chromatography Fractionation & Mass Spectrometry
The iTRAQ® labeled sample was re-suspended in buffer A (10 mM ammonium formate pH 10 in 98:2 water:acetonitrile) and fractionated offline by high pH C18 reversed-phase (RP) chromatography. A MAGIC 2002 HPLC (Michrom BioResources, Inc.) was used with a C18 Gemini-NX column (150 mm x 2 mm internal diameter, 5 µm particle, 110 Å pore size (Phenomenex). The flow rate was 150 µl/min.
with a gradient from 0-35% Buffer B (10 mM ammonium formate, pH 10 in 10:90 water:acetonitrile) over 60 min, followed by 35-60% over 5 min. Fractions were collected every 2 min and UV absorbances were monitored at 215 nm and 280 nm. Peptide containing fractions were divided into two equal numbered groups, "early" and "late". The first "early" fraction was concatenated with the first "late" fraction, and so on (18) . Concatenated samples were dried in vacuo, resuspended in load solvent (98:2:0.01, water:acetonitrile:formic acid), and 1.5 µg aliquots were run on a Velos Orbitrap mass spectrometer (Thermo Fisher Scientific, Inc.) as described previously with the exception that the activation energy was 40 ms (19) .
Database Searching, Protein Identification, and Quantitation
The mass spectrometer RAW data (Proteowizard files) were converted to mzXML using MSconvert software and to MGF files using TINT raw-to-mgf converter (http://github.com/jmchilton/tint). Search parameters were as follows: cysteine MMTS; iTRAQ 8plex (Peptide Labeled); trypsin; instrument Orbi MS (1-3ppm) Orbi MS/MS; biological modifications ID focus; thorough search effort; and false discovery rate analysis (with reversed database). Proteins were accepted if they were identified by two or more unique peptides and fell within the 5% local false discovery rate cutoff in all of the biological replicates. Relative quantification of each protein was performed using ProteinPilot 4.5 (AB Sciex, Foster City, CA) with bias correction. Each ND sample (tag 113 -115) was used as a denominator and protein summary results were exported to Microsoft Excel. The HFD/ND ratios and the corresponding pvalues from each report were combined, yielding 9 total HFD/ND ratios. A subset of proteins was generated with the following criteria: Protein Pilot p-values < 0.05 for 6 out of 9 protein ratios and a log fold change of ≥ 0.55 or ≤ -0.55, and two times the standard deviation of the nine ratios was not greater than the average log fold change.
Microscopy and Immunoblotting
Formalin-fixed-paraffin-embedded liver sections were processes for immunohistochemistry using standard methodologies. Slides were examined using a Nikon A1 Spectral Confocal Microscope and NIS Elements imaging software. The nucleus was stained with DAPI and perilipin 2 (PLIN2) was immunolabeled with chicken polyclonal primary antibody (Abcam, Cambridge MA, ab37516) and Rhodamin Red-X-conjugated donkey anti-chicken secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA). Acyl-CoA synthetase 1 (ACSL1) was immunolabeled with goat primary antibody (Santa Cruz Biotechnology) and Alexa-Fluor 647 conjugated donkey anti-goat secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA).
Similarly, carnitine palmitoyltransferase-2 (CPT2), glucose phosphate isomerase (GPI), malic enzyme (ME), and ribosomal protein, large, P0 (RPLP0) were labeled with a specific primary antibodies (One World Lab, San Diego, CA) and Alexa-Fluor 488 anti-rabbit secondary antibody (Cell Signaling 
RESULTS
To identify the hepatic LD-associated proteome, LD droplets were isolated from freshly excised livers of C57Bl/6 mice that had been fed either a ND or HFD diet for nine weeks. H&E stained liver sections (Fig. 1A) show that the HFD fed mice accumulated more LDs than the ND mice as expected.
Post-nuclear supernatant and LD fractions were evaluated for purity based on the presence of common co-purifying organelles using Western blotting of marker proteins ( Fig. 1B and Supplemental Fig. 1 ).
These data show that the LD fraction is highly enriched for the LD marker PLIN2 while we were unable to detect common ER (BIP), mitochondrial (COXIV), cytosolic (ATPCL), plasma membrane (Anexin-2), and endosome (EEA1) contaminating proteins. However, the peroxisomal marker protein, catalase, was not depleted in the LD fraction. Although the LD fraction is largely free of contaminant proteins, the sucrose centrifugation method to isolate LD does yield some contaminant proteins, as has been reported in other LD proteomic studies (14) (15) (16) .
Following LC-MS/MS analysis, we identified 1520 LD-associated proteins (Supplemental Table 1 ).
The proteins identified through this method are proteins that are associated with the LD fraction and are not necessarily bona-fide LD proteins confirmed to reside primarily or exclusively on the LD and, thus, will be referred to as LD-associated proteins. For comparison, a list of the LD-associated proteins identified by previous proteomic studies of mammalian cells and tissues was compiled (10, 11, 15, 16, 31, (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . To decrease the likelihood of similar isoforms preventing a protein match, we used the UniProt Reference Clusters 50 (UniRef50), which merges proteins of similar sequence to one UniRef entry. We compared the UniRef50 and gene symbol identifiers between the previously identified LD proteins and our protein list (24). From this analysis, we determined that 671 out of 1520 proteins identified have been reported in previous mammalian LD proteomics studies. In addition, 72% and 95% of the proteins found in previous studies on human (14) and mouse (15) hepatic LD, respectively, were identified in our analysis (Supplemental Table 1 ). Using confocal microscopy we show that 3 of these proteins, RPLP0, GPI, and ME1, show partial colocalization with the LD marker protein PLIN2 in mouse liver tissue sections (Supplemental Fig. 2 ). It should be noted that these proteins do not primarily localize to LDs and the small amount of colocalization would suggest that these, and perhaps many other proteins identified,
are not abundant LD-associated proteins.
We next performed functional annotation of the hepatic LD-associated proteome. The top five We also performed a Canonical Pathway Analysis using IPA and show the top 30 enriched canonical pathways (Fig. 2B ). The most significantly enriched pathways are eIF2 signaling, mitochondrial dysfunction, fatty acid β-oxidation I, and clathrin-mediated endocytosis signaling. Since our dataset identified more LD-associated proteins than previous mammalian LD proteomic datasets, we were unsure if the same pattern of organelle interactions would be observed. We used a GO slim assignment software to assign cellular component GO terms to both the novel and previously identified proteins from our dataset (21) . The proportions of the cellular components are nearly identical to previous studies ( Fig. 2C) ,
suggesting that the increased number of proteins we identified was not due to new organelle associations.
After filtering for statistical significance, 48 proteins were increased and 52 proteins decreased in response to high fat feeding and development of hepatic steatosis (Table 1 ). Of the proteins that were increased, 8 were also increased on LDs in humans with NAFLD (Table 1, Supplemental Table 1 ) (14) .
IPA was used to identify biological function category enrichment (Fig. 3A) . The increased functional categories of endocrine system disorders and energy production are consistent with the insulin resistance and altered lipid metabolism that characterize high fat fed mice. Canonical Pathway Analysis using IPA ( Fig. 3B and Table 2 ) revealed that the most significantly enriched pathways for the increased proteins are those involved in fatty acid metabolism. Numerous LD-associated proteins were also decreased in pathways involving liver X and retinoic acid receptor activation, coagulation and prothrombin activation pathways, glucose metabolism and clathrin-mediated endocytosis. As in the entire dataset, we used a GO slim assignment software to assign cellular component GO terms to the regulated proteins ( Fig. 3C and Table 3 ) (21) . A greater proportion of endoplasmic reticulum and ribosomal proteins are in the increased dataset, whereas a greater proportion of extracellular and cytosolic proteins were decreased in response to high fat feeding.
Two of the most robustly induced LD-associated proteins in response to the HFD were long chain acyl-CoA synthetase 1 (ACSL1) and carnitine palmitoyl transferase 2 (CPT2). ACSL1 has been identified to activate long chain fatty acids and selectively channel them to mitochondrial β-oxidation (43) (44) (45) , and has also been shown to be present on LDs in addition to its primary location on other organelles (13, 15) . CPT2 is an inner mitochondrial membrane protein important for fatty acid transport and activation. Using confocal microscopy we found both ACSL1 and CPT2 to have more co-localization with the LD marker protein PLIN2 in response to high fat feeding (Fig. 4) . Despite increased colocalization on LDs in response to high fat feeding, the staining patterns of ACSL1 and CPT2 were very different. Only a small amount of ACSL1 was found on LDs and it was generally confined to one region of a given LD. In contrast, much more CPT2 was found on LDs and it surrounded LDs similar to PLIN2
or other bona-fide LD proteins (Fig. 4) . As a control, we stained mouse liver sections with a mitochondrial protein that was not identified in our proteomics screen. VDAC, a inner mitochondrial membrane protein, stained mitochondria in the cell but did not show co-localization with LD marker protein PLIN2 (Supplemental Fig. 3 ). To further explore LD-mitochondria interactions, we examined electron microscopy micrographs of normal and high-fat fed mouse livers. We quantified the number of mitochondria and LDs and calculated the percent of mitochondria interacting with LD and the percent of LDs interacting with mitochondra. These data revealed that approximately 40% of LDs were in contact with mitochondria and 5% of mitochondria were in contact with LDs, but there was no change in either of these parameters between mouse livers fed ND or HFD (Supplemental Fig. 4 ). Consistent with these data, we also did not observe an enrichment of mitochondria proteins in our GO analysis (Fig. 3C ).
Taken together, these data support the proteomic analysis showing proteins involved in lipid catabolism are enriched on LDs in response to high fat feeding and hepatic steatosis and suggest that they are not the result of increased organelle interactions.
The nature of the interaction between primarily non-LD localized proteins and the LD is unclear in most cases. The LD comes in contact to other organelles, so it is possible that other organelles, membrane fragments, and/or proteins co-purify with the LD fraction. It is also possible that some of these proteins do indeed reside on the LD, but in a very transient or low stoichiometric basis. To represent the variety of proteins identified in the LD-associated protein dataset, we built a network using Cytoscape 3.0.1 with the ClueGO plugin (Fig. 5) . Consistent with these LD-organelle interactions, many of the proteins in our dataset are annotated with multiple cellular components and/or biological functions, as shown by the many connecting edges. Nodes, which are GO terms, were selected to represent the variety of organelle interactions.
Discussion
These data provide a quantitative analysis of changes in the hepatic LD-associated proteome in response to a model of diet-induced hepatic steatosis. Our analysis identified many proteins that have been previously found in LD proteomic analysis. We also found a greater number of proteins than previous hepatic LD proteomic analysis, which may in part be due to the higher level of detection of the mass spectrometer used in the current study or different LD isolation or analytical methodologies. A limitation of any proteomics study including the current one is determining if proteins identified in our analysis are bona-fide LD proteins or contaminants. We did not detect contamination, via Western blotting, of any organelle except peroxisomes. However, Western blotting is much less sensitive than mass spectrometry. As an example, we found the organelle markers ATP-CL and β-actin in our mass spectrometry analysis of LD-associated proteins, but we were unable to detect them in the LD fraction by Western blotting. Thus, it is difficult to distinguish between bona-fide LD proteins and contaminant proteins as is the case in any proteomic study. Additionally, many LD-associated proteins may be associated with LDs, but this only represents a small amount of the total intracellular distribution. Indeed, we found that several LD-associated proteins colocalized with PLIN2, but most of the proteins resided primarily in other intracellular locations. An additional caveat of these studies is that although PLIN2 is the most abundant hepatic LD protein, it does is not present on all hepatic LDs and, therefore, is an imperfect LD marker (46).
Krahmer et al. recently used a protein correlation profiles strategy to identify high confidence LD proteins from Drosophila SH2 cells (47) . Given that this study identified a similar total number of proteins to our study (1481 vs. 1520), we determined the mammalian orthologs of the entire Drosophila LD protein dataset and compared them to our dataset (25). Roughly half of their proteins (694) matched to the mammalian orthologs of our list (Supplemental Table 1 ). We also compared the bona-fide LD proteins from Krahmer et al. to our dataset; seven of the Drosophila proteins had no mouse ortholog by our analysis. Of the 111 proteins they identified as bona-fide LD proteins, we found 60 homologues in our proteomic analysis.
The canonical pathway of fatty acid β-oxidation was enriched in our screen along with many proteins involved in lipid metabolism. We identified enzymes of both peroxisomal and mitochondrial fatty acid oxidation. Tight interaction between LDs and the peroxisome has been previously reported (48, 49) .
Consistent with these data, we detected peroxisomal marker protein, catalase, in our LD fraction both by mass spectrometry and Western blot (Supplemental Figure 1 and Supplemental Table 1 ). We identified the mouse homologs for 7 of the 8 yeast proteins involved in peroxisomal β-oxidation that were identified in a previous LD screen in yeast (48) . It has also been demonstrated that the mitochondria directly interact with LDs (16, 50, 51) . Consistent with this tight interaction, the most highly enriched GO annotation cluster by DAVID analysis was mitochondrial part (data not shown).
In addition to mitochondria and peroxisomes, many organelles are in close proximity to LDs. ER proteins also commonly co-purify with the LD fraction, which may be due to the fact that the ER, the Pathways involving fatty acid catabolism were highly increased in the LD proteome in response to high fat feeding. Isoform 2 of dynamin-like 120 kDa protein (OPA1), which was increased on LD following high fat feeding, has been shown to regulate protein kinase A-mediated lipolysis (57).
Consistent with increased lipolysis, monoglyceride lipase (MGLL) was also enriched in LD from mice fed the HFD. ACSL1 has been shown to promote the activation of fatty acids destined for mitochondrial oxidation in numerous tissues (43) (44) (45) . The mitochondrial L-carnitine shuttle pathway is enriched due to the increase of carnitine palmitoyl transferase 2A (CPT2), which converts medium-and long-chain acylcarnitines into acyl-CoAs that can be used for β-oxidation. Very long chain acyl-CoA dehydrogenase (ACADVL), which catalyzes the first step of β-oxidation in the mitochondria, was also enriched in LD in response to the HFD. In support of this data, ACADVL, ACSL1, MGLL and CPT2 were also found in higher abundance on hepatic LD in human subjects with NAFLD suggesting that these proteins are conserved in models of NAFLD (14) . Taken together, these data are consistent with more recent studies showing that FA oxidation is upregulated in models of hepatic steatosis (58) (59) (60) . Recent studies in nonhepatocytes cell lines suggest that LD-mitochondria interactions are important for oxidation of hydrolyzed fatty acids (61) . However, our studies do not show increased LD-mitochondria interactions in response to high fat feeding. Clearly, much remains to be learned regarding the factors governing the oxidation of hydrolyzed fatty acids in the liver and how this changes during the development of steatosis.
We also observed an increase in many ribosomal and ER proteins on hepatic LDs in high fat fed mice. Ribosomal proteins have been previously observed on LDs in leukocytes via electron microscopy (40) and numerous ribosomal proteins including eukaryotic initiation factor 1a were found on LDs in Drosophila (62) . Previous Drosophila RNAi screens have found that the knockdown of ribosomal proteins increases LD storage (63, 64) . In obese mouse livers, ER-associated protein synthesis and the number of ribosome proteins bound to the ER membrane was found to be decreased, while lipid metabolism was increased (65, 66) . It has been postulated that LDs provide a reservoir for unfolded proteins and toxic lipids from the ER, because during times of ER dysfunction, LDs accumulate (67) . In addition, the increase in ER proteins may simply represent elevated LD biogenesis as discussed above.
Proteins involved in glycolysis including pyruvate kinase, phosphoglycerate mutase and glucose-6-phospate isomerase were specifically depleted in hepatic LD from mice fed the high fat diets. Crunk et al.
(15) also identified pyruvate kinase and phosphoglycerate mutase as hepatic LD-associated proteins and found that numerous proteins involved in carbohydrate metabolism were also decreased on LDs in response to acute high fat feeding. Glycolytic enzymes are known to interact with caveolae (68), which are well-documented to be tightly linked to LD biogenesis and metabolism (69, 70) . Additionally, the absence of caveolin-1 results in enhanced glycolysis (71) suggesting that alterations in the LD-associated proteome could directly influence carbohydrate metabolism.
It is not immediately clear why extracellular proteins would localize intracellularly to the LD or why their localization would be affected by hepatic steatosis; however, many of the identified extracellular proteins have links to hepatic steatosis, obesity and diabetes (72) (73) (74) (75) (76) . Additionally, it is not clear if these extracellular proteins are in the secretory pathway or are being endocytosed. However, in support of the latter, proteins involved in endosomal trafficking have been identified on LDs previously (77) .
Additionally, multivesicular bodies/late endosomes interact with LDs in hepatocytes suggesting that protein transfer could occur (78) . The decreased presence of secreted proteins accounts for the reduction of numerous canonical pathways in response to high fat feeding including liver X and retinoic acid receptor activation, coagulation system acute phase response signaling and prothrombin activation pathways.
In summary, our analysis has more comprehensively defined the hepatic LD-associated proteome and for the first time quantified the dynamic regulation of LD-associated proteins during chronic diet-induced hepatic steatosis. These data provide novel insights into complexity of LD biology and point towards unique functions of LDs beyond simple lipid storage organelles. Table 2 . Canonical pathway analysis of LD proteins regulated by diet and proteins within each component that were significantly altered. Figure 4 
